Chris Goodman

Chris Goodman is an accomplished executive in the field of quality and regulatory affairs, currently serving as Vice President at OrganaBio since June 2022, where responsibilities include navigating complex regulatory requirements for advanced cellular therapy products. Previously, Chris held multiple leadership roles including Vice President of Regulatory Affairs and Quality Assurance at OrganaBio, Managing Director at Square One Priorities, and Chairman of Qatar's Biomedical Research Institutional Biosafety Committee. Chris has extensive experience, having served as Director and Chief Executive Officer at Virgin Health Bank and Director of Operations at Celgene. Educational background includes a Master’s degree in Human Cytogenetics from Hofstra University and a Bachelor of Science in Biological Sciences from California Polytechnic State University-San Luis Obispo.